Australian Pharmaceutical Industries Limited (API)



Welcome to InvestSMART

You are currently viewing our site as a guest, which gives you limited access to our site features. By signing up for a free membership, you will receive our Investment Opportunity newsletters and have access to additional features for finding and comparing managed funds and shares. Registration is fast and simple, so please:

Sign Up Today Ľ it's FREE! Already a member? Login now!


General Information
Company Name: Australian Pharmaceutical Industries Limited
Stock Code: API
Website: www.api.net.au
GICS Sub-Industry: Health Care Distributors
Market Cap ($M): 271
Equiv. Shares (M): 488

Current Price Data+
Current Price Open High Low Last Close Volume Price Movement
$ 0.555 $ 0.570 $ 0.572 $ 0.555 $ 0.555 350,949 0%

Current Broker Consensus Recommendation more
Recommendation: Buy (2)
Recommendation Date: 19th Aug 2014
Brokers Surveyed: 2

Company Overview

Business Description:
Australian Pharmaceutical Industries Limited (API) is an Australian health and beauty services company. API provides wholesale product delivery services, retail services, marketing programs and business advisory services to customers. API also has as a number of brands and banners in the retail health and beauty industry, including Priceline, Soul Pattinson and Pharmacist Advice. API has three main businesses namely, Pharmacy Distribution, Manufacturing and Retail.

Strategy Analysis:
Under the 'Revitalise' plan, a new network plan is forecasted to reduce $18m in annualised cost over 3 years. Total required investment for the program is approximately $60m. Goals include: combining two supply chains into a single system to reduce inventory and freight costs; increase automation at distribution centres; and IT improvements. Revitalise program to consolidate Supply Chain is expected to deliver savings in FY11 of $10m and $18m in FY12. In its retail operations, management is looking to transfer further Priceline corporate stores to franchises. API will also focus is on organic growth in pharmacy and retail operations, as well as improving cost efficiencies.. Australian Pharmaceutical Industries reported NPAT of $30.28m for the year ended 31 August 2012. Revenue from ordinary activities were $3.22bn, down 6.1% from last year. Basic and Diluted EPS were 6.2 cents compared to (4.8) cents last year. Net operating cash flow was $47.82m compared to $48.21m last year. The final dividend declared was 1.5 cents, taking the full year dividend to 3 cents compared with 2.5 cents last year.


Financial Summary
Year to Aug NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2013  A 24.3 5.0 56.3 9.1 3.3 7.2 100.0
2012  A 15.7 3.2 -- 9.3 3.0 10.0 100.0
2011  A -19.7 -4.0 -178.4 0.0 2.5 6.7 40.0
Source: Morningstar analyst estimates.

Peer Comparison
EPS Growth (%) P/E (%) Dividend Yield (%)
Company Mkt Cap 2011 A 2012 F 2013 F 2011 A 2012 F 2013 F 2011 A 2012 F 2013 F
Australian Pharmaceutical Industries (API) $273 M 0.5465 0.1305 0.0959 11.2450 9.9467 9.0762 5.80 6.14 6.80
Primary Health Care (PRY) $2,321 M 0.0787 0.1062 0.0901 14.2547 12.8860 11.8208 4.36 4.86 5.31
Sonic Healthcare (SHL) $7,062 M 0.1328 0.1133 0.0797 18.4503 16.5726 15.3498 3.80 4.20 4.63
Sigma Pharma. (SIP) $920 M -0.2237 0.0961 0.1155 18.1223 16.5339 14.8214 4.82 2.41 5.40

Market Comparison
Earnings P/E Ratio P/B Ratio P/E Growth P/S Ratio
API 0.54 9.91 0.46 0.87 0.08
Market 0.99 16.4 1.31 2.17 1.69
Sector 0.66 22.0 2.67 1.66 2.64

Directors
Name Position Start Date
Mr Stephen Roche Chief Executive Officer,Managing Director 14 August 2006
Mr Peter Raymond Robinson Non-Executive Chairman 05 May 2000
Mr Robert Dobson Millner Non-Executive Director 12 May 2000
Ms Esther Carol Holley Non-Executive Director 19 December 2006
Mr Gerry Masters Non-Executive Director 07 September 2010
Mr Kenneth William Gunderson-Briggs Non-Executive Director 06 May 2014
Dr Michael Wooldridge Non-Executive Director 01 February 2006
Ms Lee Ausburn Non-Executive Director 07 October 2008

Management
Name Position
Peter F Sanguinetti Company Secretary
Genevieve Joy Browne Company Secretary

Substantial Shareholders
Holding Name
32,138,866 (6.58%) Citicorp Nominees Pty Limited
120,214,969 (24.63%) Washington H Soul Pattinson and Co Ltd
58,122,597 (11.91%) S L Nominees Pty Ltd and Associates
31,110,561 (6.37%) J P Morgan Nominees Australia Limited

Calendar of Events
Date Event
29 April 2015 Report (Interim)
12 December 2014 Report (Annual)
23 October 2014 Report (Prelim)
© 2011 Morningstar, Inc. All rights reserved. The data and content contained herein are not guaranteed to be accurate, complete or timely. Neither Morningstar, nor its affiliates nor their content providers will have any liability for use or distribution of any of this information. To the extent that any of the content above constitutes advice, it is general advice that has been prepared by Morningstar Australasia Pty Ltd ABN: 95 090 665 544, AFSL: 240892 (a subsidiary of Morningstar, Inc.), without reference to your objectives, financial situation or needs. Before acting on any advice, you should consider the appropriateness of the advice and we recommend you obtain financial, legal and taxation advice before making any financial investment decision. If applicable investors should obtain the relevant product disclosure statement and consider it before making any decision to invest. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). DISCLOSURE: Employees may have an interest in the securities discussed in this report. Please refer to our Financial Services Guide (FSG) for more information at www.morningstar.com.au/fsg.asp.

Advertisement

Trade Shares Online from $19.95^
Free Guides

The SMH Guide to Choosing A Financial Planner

An educational booklet about the specialised professionals who help people with their money-related requirements - especially superannuation.

More details...

News

Billionaires bankroll Ten's new direction Media Network sees digital future

The Age 19/12/2013 | Ten Network's programming ambitions will be funded by a $200 million loan guaranteed by three of its billionaire owners, as the free-to-air broadcaster declared digital was the future and pointed to early signs that its switch to an older market demographic was working.

Elders alleges $24m fraud in live cattle division

The Age 19/12/2013 | Troubled rural services group Elders is threatening to call in the police over an alleged $24 million fraud by a "handful of individuals" in its live cattle exports division.

Bega Cheese holds back in three-way bidding war for WCB

The Age 19/12/2013 | Bega Cheese began the battle for Warrnambool Cheese & Butter but three months on it appears to be the first casualty of the bidding war.

Aussie hampers transition

The Age 19/12/2013 | A persistently high Australian dollar is thwarting the Reserve Bank's efforts to ease the transition of the economy away from mining.

RBA keeps its focus on lower dollar

The Age 19/12/2013 | The Reserve Bank is keeping the door open to further interest rate cuts, but believes the "significant amount" of monetary policy easing over the past two years is already stimulating growth.

Pact's struggles weigh down Orora

The Age 19/12/2013 | The underwhelming sharemarket debut of packaging company Pact Group Holdings has weighed on the demerger of Amcor and its $2 billion Australasian packaging and distribution business Orora.

More...


Sponsored Links